These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6751023)

  • 21. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.
    Berger M; Halban PA; Girardier L; Seydoux J; Offord RE; Renold AE
    Diabetologia; 1979 Aug; 17(2):97-9. PubMed ID: 488572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of major surgery on absorption rate of NPH insulin injected s.c.
    Hjortrup A; Madsbad S; Andersen M; Sørensen C
    Br J Anaesth; 1990 Jun; 64(6):741-2. PubMed ID: 2378778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent mental stress and insulin absorption in normal subjects.
    Fernqvist E; Linde B
    Diabetes Care; 1988 Sep; 11(8):650-5. PubMed ID: 3065003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of insulin following intravenous and subcutaneous administration in canines.
    Ravis WR; Comerci C; Ganjam VK
    Biopharm Drug Dispos; 1986; 7(5):407-20. PubMed ID: 3535917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
    Bantle JP; Neal L; Frankamp LM
    Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion and polymerization determines the insulin absorption from subcutaneous tissue in diabetic patients.
    Hildebrandt P; Sejrsen P; Nielsen SL; Birch K; Sestoft L
    Scand J Clin Lab Invest; 1985 Dec; 45(8):685-90. PubMed ID: 3909370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM.
    Frid A; Ostman J; Linde B
    Diabetes Care; 1990 May; 13(5):473-7. PubMed ID: 2190773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model.
    Fischer U; Freyse EJ; Jutzi E; Besch W; Raschke M; Höfer S; Albrecht G
    Diabetologia; 1983 Mar; 24(3):196-201. PubMed ID: 6341148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in 125I-insulin absorption and blood glucose concentration.
    Lauritzen T; Faber OK; Binder C
    Diabetologia; 1979 Nov; 17(5):291-5. PubMed ID: 499686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique.
    Thow JC; Johnson AB; Fulcher G; Home PD
    Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.
    Thow JC; Johnson AB; Marsden S; Taylor R; Home PD
    Diabet Med; 1990 Nov; 7(9):795-9. PubMed ID: 2148131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous injection with an insulin pen. Insulin absorption and plasma concentrations of glucose and free insulin.
    de Meijer PH; Lutterman JA
    Neth J Med; 1990 Feb; 36(1-2):4-12. PubMed ID: 2179752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porcine and human insulin absorption from subcutaneous tissues in normal and insulin-dependent diabetic subjects: a deconvolution-based approach.
    Nosadini R; De Kreutzenberg S; Duner E; Iori E; Avogaro A; Trevisan R; Fioretto P; Doria A; Merkel C; Cobelli C
    J Clin Endocrinol Metab; 1988 Sep; 67(3):551-9. PubMed ID: 3045144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antihypertensive drugs on insulin absorption.
    Veenstra J; van der Hulst JP; Wildenborg IH; Njoo SF; Verdegaal WP; Silberbusch J
    Diabetes Care; 1991 Nov; 14(11):1089-92. PubMed ID: 1797494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.